Skip to main content
TipRanks
Go Ultimate75% OFF

4D Molecular Therapeutics (FDMT) Drug Pipeline

535 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
4D-150 Ivt, Eyelea Injection 2 MgDiabetic Macular Edema (Dme)Phase IIIRecruitingA Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).Oct 05, 2026―
4D-150 Ivt, Eylea Injection 2 MgNeovascular Age-Related Macular Degeneration (Namd)Phase IIIRecruitingSingle Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationJul 07, 2025
4D-150 Ivt, Eylea Injection 2 MgMacular Neovascularization Secondary To Age-Related Macular DegenerationPhase IIIActive Not Recruiting4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationMar 04, 2025
4D-150 Ivt, Aflibercept IvtDiabetic Macular Edema, Diabetic RetinopathyPhase IIActive Not Recruiting4D-150 in Patients With Diabetic Macular EdemaJun 26, 2023―
4D-310Fabry Diseasephase1AndPhase2Recruiting4D-310 in Adults With Fabry Disease and Cardiac InvolvementNov 04, 2022
4D-710Cystic Fibrosis LungPhase IIRecruiting4D-710 in Adult Patients With Cystic FibrosisFeb 10, 2022
4D-150 Ivt, Aflibercept IvtNeovascular (Wet) Age-Related Macular Degenerationphase1AndPhase2Recruiting4D-150 in Patients With Neovascular (Wet) Age-Related Macular DegenerationJan 05, 2022
Observational, 4D-125 Ivt InjectionX-Linked Retinitis Pigmentosaphase1AndPhase2Active Not Recruiting4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)Aug 14, 2020―
4D-110ChoroideremiaPhase IActive Not RecruitingDose Escalation Study of Intravitreal 4D-110 in Patients With ChoroideremiaJul 20, 2020―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does 4D Molecular Therapeutics, Inc. (FDMT) have in its pipeline
4D Molecular Therapeutics FDMT is currently developing the following drugs: 4D-150 Ivt, Eyelea Injection 2 Mg, 4D-150 Ivt, Eylea Injection 2 Mg, 4D-150 Ivt, Aflibercept Ivt, 4D-310, 4D-710, Observational, 4D-125 Ivt Injection, 4D-110. These drug candidates are in various stages of clinical development as the company works toward FDA approval.